Hôpital Henri-Mondor AP-HP
73 currently recruiting clinical trials
Phase 3
Prostate cancer
#NCT07028853
#2024-519369-24-00
Required histologic sub types
Adenocarcinoma
Required disease stage
Metastatic Hormone-sensitive
Required number of previous lines of therapy for current stage of disease
None
Excluded previous treatments at advanced or metastatic stage
Chemotherapy
Hôpital Henri-Mondor AP-HP (Créteil)
Pfizer
Phase 3
Skin cancer
#NCT05078047
Cancer de Merkel, mélanome, carcinome basocellulaire ou carcinome épidermoïde de la peau
Required histologic types
Melanoma
Basal cell carcinoma
Squamous cell carcinoma
Merkel cell carcinoma
Required disease stage
Locally Advanced
Metastatic
Required previous treatments at advanced or metastatic stage
Immunotherapy
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Henri-Mondor AP-HP (Créteil)
UNICANCER
Phase 3
Amyloidosis
#NCT07207811
#2024-518899-31-00
Required histologic types
Other
Required organ involvement status
Presence
Required organ involvements
Cardiac
Hôpital Henri-Mondor AP-HP (Créteil)
Novo Nordisk A/S
Phase 3
Lymphoma
#NCT06006117
#2022-501810-77-00
Required histologic types
B cell lymphoma
Required histologic sub types
Marginal zone lymphoma
Required central nervous system lesions
None
Required renal function statuses
> 60 ml/min
50-60 ml/min
30-50 ml/min
Required number of previous lines of therapy
1
2
3 or more
Required previous treatments
Chemotherapy
Targeted therapy
Monoclonal antibodies
Excluded previous treatments
Systemic Treatment-Naive
Bispecific T-cell engager antibodies
Allogeneic stem cell transplant
Hôpital Henri-Mondor AP-HP (Créteil)
The Lymphoma Academic Research Organisation (LYSARC)
Phase 3
Lymphoma
#NCT06284122
#2023-505436-35-00
Required histologic types
B cell lymphoma
Required histologic sub types
Follicular lymphoma
Required renal function statuses
30-50 ml/min
< 30 ml/min
Required number of previous lines of therapy
None
Required previous treatments
Systemic Treatment-Naive
Excluded previous treatments
Allogeneic stem cell transplant
Radiotherapy
Hôpital Henri-Mondor AP-HP (Créteil)
The Lymphoma Academic Research Organisation (LYSARC)
Phase 3
Kidney cancer
#NCT07227402
#2024-517136-21-00
Required histologic types
Clear cell carcinoma
Required disease stage
Locally Advanced
Metastatic
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Immunotherapy
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Henri-Mondor AP-HP (Créteil)
Merck Sharp & Dohme LLC
Phase 3
Multiple myeloma
#NCT06615479
#2024-515279-37-00
Required histologic types
Symptomatic multiple myeloma
Required histologic sub types
Monoclonal component measurable
Required central nervous system lesions
None
Required number of previous lines of therapy
1
2
3 or more
Required previous treatments
Monoclonal antibodies
Proteasome inhibitor
Immunomodulator
Excluded previous treatments
Systemic Treatment-Naive
Hôpital Henri-Mondor AP-HP (Créteil)
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 3
Multiple myeloma
#NCT06918002
#2024-516418-39-00
Required histologic types
Symptomatic multiple myeloma
Required histologic sub types
Monoclonal component measurable
Required central nervous system lesions
None
Required number of previous lines of therapy
None
Required previous treatments
Systemic Treatment-Naive
Hôpital Henri-Mondor AP-HP (Créteil)
Intergroupe Francophone du Myélome
Phase 3
Multiple myeloma
#NCT05552222
#2022-000909-28
Required histologic types
Symptomatic multiple myeloma
Required number of previous lines of therapy
None
Required previous treatments
Systemic Treatment-Naive
Hôpital Henri-Mondor AP-HP (Créteil)
Janssen
Phase 3
Multiple myeloma
#NCT06152575
#2023-507871-23-00
Required histologic types
Symptomatic multiple myeloma
Required histologic sub types
Monoclonal component measurable
Required central nervous system lesions
None
Required number of previous lines of therapy
1
2
3 or more
Required previous treatments
Monoclonal antibodies
Immunomodulator
Excluded previous treatments
Systemic Treatment-Naive
Hôpital Henri-Mondor AP-HP (Créteil)
Pfizer